🇺🇸 Topiramate 100mg in United States

18 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nephrolithiasis — 3 reports (16.67%)
  2. Vomiting — 3 reports (16.67%)
  3. Diarrhoea — 2 reports (11.11%)
  4. Drug Interaction — 2 reports (11.11%)
  5. Paraesthesia — 2 reports (11.11%)
  6. Product Substitution Issue — 2 reports (11.11%)
  7. Abdominal Distension — 1 report (5.56%)
  8. Acute Kidney Injury — 1 report (5.56%)
  9. Aggression — 1 report (5.56%)
  10. Agitation — 1 report (5.56%)

Source database →

Topiramate 100mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Topiramate 100mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Topiramate 100mg in United States?

University of Minnesota is the originator. The local marketing authorisation holder may differ — check the official source linked above.